OBESITY OR OVERWEIGHT
Clinical trials for OBESITY OR OVERWEIGHT explained in plain language.
Never miss a new study
Get alerted when new OBESITY OR OVERWEIGHT trials appear
Sign up with your email to follow new studies for OBESITY OR OVERWEIGHT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New daily pill shows promise for obesity weight loss in phase 2 trial
Disease control OngoingThis study tests an experimental drug called RO7795081, taken once daily for 38 weeks, to help adults with obesity or overweight who also have weight-related health problems (like high blood pressure or sleep apnea) lose weight. About 352 participants will receive either the drug…
Matched conditions: OBESITY OR OVERWEIGHT
Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 17, 2026 04:15 UTC
-
New shot combo aims to supercharge weight loss in obesity
Disease control OngoingThis study tests whether combining two experimental weekly injections (AZD9550 and AZD6234) helps people with obesity or overweight who also have weight-related health problems lose more weight than placebo or either drug alone. About 377 adults aged 18-75 with a BMI of 27 or hig…
Matched conditions: OBESITY OR OVERWEIGHT
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 15, 2026 11:54 UTC